http://www.bbcweb3hytmzhn5d532owbu6oqadra5z3ar726vq5kgwwn6aucdccrad.onion/news/world-asia-india-55748124
Covaxin, made by Bharat Biotech, has been granted emergency use permission for the six-12 age group, health minister Mansukh Mandaviya tweeted. It is already administered to children aged 12-18, and adults. Two other vaccines have also been given emergency approval - Corbevax for children aged five-12; and Zydus's two-dose jab for children above 12.